Jiangsu Nanfang Medical (SH:603880) Zheng Quan Zhi Xing·2025-06-18 13:12Group 1 - The company will hold an investor briefing on June 27, 2025, from 13:00 to 14:00 to discuss its 2024 annual and 2025 Q1 performance [1][2] - The briefing will take place at the Shanghai Stock Exchange Roadshow Center and will be conducted in an interactive online format [2][4] - Key personnel attending the meeting include the Chairman, General Manager, Secretary of the Board, Chief Financial Officer, and an Independent Director [2] Group 2 - Investors can submit questions for the briefing from June 20, 2025, to June 26, 2025, by logging into the Shanghai Stock Exchange Roadshow Center or via the company's email [3] - The company will address commonly asked questions during the briefing, ensuring transparency and engagement with investors [2][3] - After the briefing, investors can access the meeting's details and main content through the Shanghai Stock Exchange Roadshow Center [4]